Business
HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026
HEALWELL achieved quarterly revenue from continuing operations of $33.2 million in Q1-2026, an in...
About this update from Healwell Ai Inc. Class A
[{"type":"text","content":"HEALWELL Delivers 316% Revenue Growth and Increasing Customer Traction in Q1-2026HEALWELL achieved quarterly revenue from continuing operations of $33.2 million in Q1-2026, an increase of 316% compared to revenue of $8.0 million generated in Q1-2025. Revenue growth in the quarter was largely driven by the Orion Health acquisition and organic growth of the Company's AI division. HEALWELL reported positive Adjusted EBITDA of $0.7 million in Q1-2026, compared to an Adjusted EBITDA loss of $2.3 million in Q1-2025, representing a year-over-year improvement of 132%. The improvement in Adjusted EBITDA is attributable to the Orion Health acquisition and improved performance across HEALWELL operating segments. The Company reported an IFRS net loss from continuing operations of $6.8 million in Q1-2026, compared to a net loss of $14.1 million in Q1-2025. During the quarter, HEALWELL secured its first AI contract with a major governmental health system in the Middle East and continued expanding enterprise deployments across North America, reinforcing the Company's growing international footprint and adoption of its AI solutions. HEALWELL signed a multi-million dollar U.S. Health Information Exchange (HIE) contract, strengthening its position in clinical data interoperability and enabling large-scale aggregation and normalization of healthcare data across hospitals, clinics, labs, and public health agencies. Toronto, Ontario--(Newsfile Corp. - May 7, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) (\"HEALWELL\" or the \"Company\"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce its unaudited interim condensed consolidated financial results for the quarter ended March 31, 2026. A summary of the Company's financial and operational results is set out below, and more detailed information is contained in the interim financial statements and related management discussion and analysis, which are available on the Company's SEDAR+ page at www.sedarplus.ca. Financial measures described as \"Adjusted\" in this news release are non-IFRS financial measures and may not be comparable to other similar measures disclosed by other companies. Please see Non-IFRS Financial Measures below for more information. James Lee, Chief Executive Officer of HEALWELL, commented, \"HEALWELL is now operating at...